Past Recipients CIC Walter Wolf Young Investigator Award

 

2018:

Sungwook Jung, PhD 

“Natural Killer cell labeled by gold-coated iron oxide nanoparticles: PET/MRI/PA monitoring and immuno-photothermal cancer therapy"

2017:

Raiyan Tripti Zaman, PhD 

“Harnessing Radioluminescence and Sound to Reveal Molecular Pathology of Atherosclerotic Plaques"

2016:

Yong-il Kim

“Prognostic Value of Pre-treatment Ga-68-RGD PET-CT in Predicting Disease Free Survival in Patients with Breast Cancer: A Comparison Study with Dynamic Contrast Enhanced MRI.” 

2015:
Chrystalla Loutsios
"SPECT/CT to quantify eosinophil migration into the lungs"

2014:
Jean-François Montégiani
Personalized 177 Lu-octreotate PPRT: cycle-to-cycle renal radiation dose prediction using quantitative SPECT/CT dosimetry

2013:
Matthias Eiber, MD, PhD
“Initial experience in restaging of patients with recurrent prostate cancer: Comparison of 11C-Choline-PET/MR and 11C-Choline-PET/CT”

2012:
Hai Jeon Yoon, MD
"Predicting histologic biomarker expression in breast cancer with 68Ga-RGD PET/CT versus diffusion-weighted and dynamic contrast-enhanced MRI"

2011:
Masahiro Yanagawa, MD, PhD
"Comparison of PET Response Criteria in Solid Tumors (PERCIST) and Response Evaluation Criteria in Solid Tumors (RECIST) in neoadjuvant chemotherapy for esophageal cancer"

2010:
Andrew Quon, MD
“Correlation between MRI and NaF PET/CT in patients with patellofemoral knee pain”

2009:
Patrick Veit-Haibach, MD
“Impact of F18-DOPA PET/CT on therapeutic management in patients neuroendocrine tumors”

2008:
Donna J. Cross, PhD
“Olfactory tract dysintegrity and cortical metabolic change in aging and MCI.”

2007:
Jan Soyka, MD
"Staging Pathways in Recurrent Colorectal Carcinoma. Is Contrast-enhanced 18-FDG-PET-CT the Diagnostic Tool of Choice?"